These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 22829694)

  • 1. Malignancy as a comorbidity in rheumatic diseases.
    Turesson C; Matteson EL
    Rheumatology (Oxford); 2013 Jan; 52(1):5-14. PubMed ID: 22829694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer in patients with rheumatic diseases exposed to TNF antagonists.
    Carmona L; Abasolo L; Descalzo MA; Pérez-Zafrilla B; Sellas A; de Abajo F; Gomez-Reino JJ; ;
    Semin Arthritis Rheum; 2011 Aug; 41(1):71-80. PubMed ID: 21093020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human leukocyte antigens class II genes are associated with cancer development in the autoimmune rheumatic diseases.
    Miranda-Duarte A; Kraus-Weisman A; Granados J; Vill AR
    Rev Invest Clin; 2011; 63(3):236-43. PubMed ID: 21888287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of developing certain malignancies is related to duration of immunosuppressive drug exposure in patients with rheumatic diseases.
    Asten P; Barrett J; Symmons D
    J Rheumatol; 1999 Aug; 26(8):1705-14. PubMed ID: 10451066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic conditions and health problems in rheumatic diseases: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, systemic lupus erythematosus, and fibromyalgia.
    Wolfe F; Michaud K; Li T; Katz RS
    J Rheumatol; 2010 Feb; 37(2):305-15. PubMed ID: 20080915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of malignancy with rheumatic and connective tissue diseases.
    Carsons S
    Semin Oncol; 1997 Jun; 24(3):360-72. PubMed ID: 9208890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tumors in rheumatic diseases].
    Świerkot J; Lewandowicz-Uszyńska A; Bogunia-Kubik K
    Postepy Hig Med Dosw (Online); 2013 Dec; 67():1254-60. PubMed ID: 24379265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiovascular comorbidity in rheumatic disease. Does sex play a role?].
    Kung M; Störk S; Angermann CE
    Herz; 2005 Sep; 30(6):512-21. PubMed ID: 16170682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rheumatic diseases as risk factors for cardiovascular disease].
    Nurmohamed MT; Voskuyl AE; van der Horst-Bruinsma IE; Dijkmans BA
    Ned Tijdschr Geneeskd; 2006 Sep; 150(35):1921-4. PubMed ID: 16999275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rheumatic manifestations of cancer.
    Ashouri JF; Daikh DI
    Rheum Dis Clin North Am; 2011 Nov; 37(4):489-505. PubMed ID: 22075194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should we be morbid about comorbidities in the rheumatic diseases?
    Elewaut D; Goodson N; Fleischmann R
    Rheumatology (Oxford); 2013 Jan; 52(1):1-2. PubMed ID: 23238977
    [No Abstract]   [Full Text] [Related]  

  • 12. Malignancy as a comorbidity in rheumatic diseases: a retrospective hospital-based study.
    Wang HL; Zhou YM; Zhu GZ; Yang Z; Hua BJ
    Clin Rheumatol; 2018 Jan; 37(1):81-85. PubMed ID: 28508950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignancies in systemic rheumatic diseases: A mini review.
    Geng Z; Ye C; Zhu X
    Front Immunol; 2023; 14():1095526. PubMed ID: 36926334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between rheumatoid arthritis and malignancy.
    Chakravarty EF; Genovese MC
    Rheum Dis Clin North Am; 2004 May; 30(2):271-84, vi. PubMed ID: 15172040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased cardiovascular risk factors in different rheumatic diseases compared with the general population.
    Meek IL; Picavet HS; Vonkeman HE; Verschuren WM; van de Laar MA
    Rheumatology (Oxford); 2013 Jan; 52(1):210-6. PubMed ID: 22847678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative assessment of vascular function in autoimmune rheumatic diseases: considerations of prevention and treatment.
    Soltész P; Kerekes G; Dér H; Szücs G; Szántó S; Kiss E; Bodolay E; Zeher M; Timár O; Szodoray P; Szegedi G; Szekanecz Z
    Autoimmun Rev; 2011 May; 10(7):416-25. PubMed ID: 21281743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignancy and autoimmunity.
    Bernatsky S; Ramsey-Goldman R; Clarke A
    Curr Opin Rheumatol; 2006 Mar; 18(2):129-34. PubMed ID: 16462517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of cardiovascular disease in patients with rheumatic diseases.
    Domsic R; Maksimowicz-McKinnon K; Manzi S
    Best Pract Res Clin Rheumatol; 2006 Aug; 20(4):741-56. PubMed ID: 16979536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soft tissue infections.
    Torralba KD; Quismorio FP
    Rheum Dis Clin North Am; 2009 Feb; 35(1):45-62. PubMed ID: 19480996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rheumatology and oncology: an updated review of rheumatic manifestations of malignancy and anti-neoplastictherapy.
    Alias A; Rodriguez EJ; Bateman HE; Sterrett AG; Valeriano-Marcet J
    Bull NYU Hosp Jt Dis; 2012; 70(2):109-14. PubMed ID: 22892000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.